79 related articles for article (PubMed ID: 29392690)
1. Establishing Primary Human Glioblastoma Tumorsphere Cultures from Operative Specimens.
Frenster JD; Placantonakis DG
Methods Mol Biol; 2018; 1741():63-69. PubMed ID: 29392690
[TBL] [Abstract][Full Text] [Related]
2. Establishing Primary Human Glioblastoma Adherent Cultures from Operative Specimens.
Gujar AD; Mao DD; Finlay JB; Kim AH
Methods Mol Biol; 2018; 1741():53-62. PubMed ID: 29392689
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.
Sassi Fde A; Caesar L; Jaeger M; Nör C; Abujamra AL; Schwartsmann G; de Farias CB; Brunetto AL; Lopez PL; Roesler R
J Mol Neurosci; 2014 Sep; 54(1):27-40. PubMed ID: 24464841
[TBL] [Abstract][Full Text] [Related]
4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
5. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
6. Isolation and culture of primary glioblastoma cells from human tumor specimens.
Seidel S; Garvalov BK; Acker T
Methods Mol Biol; 2015; 1235():263-75. PubMed ID: 25388399
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
8. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
9. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
[TBL] [Abstract][Full Text] [Related]
10. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
12. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
[TBL] [Abstract][Full Text] [Related]
13. Organotypic explant culture of glioblastoma multiforme and subsequent single-cell suspension.
Shimizu F; Hovinga KE; Metzner M; Soulet D; Tabar V
Curr Protoc Stem Cell Biol; 2011 Dec; Chapter 3():Unit3.5. PubMed ID: 22135084
[TBL] [Abstract][Full Text] [Related]
14. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS
Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951
[TBL] [Abstract][Full Text] [Related]
15. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
16. Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures.
Halle B; Thomassen M; Venkatesan R; Kaimal V; Marcusson EG; Munthe S; Sørensen MD; Aaberg-Jessen C; Jensen SS; Meyer M; Kruse TA; Christiansen H; Schmidt S; Mollenhauer J; Schulz MK; Andersen C; Kristensen BW
J Neurooncol; 2016 Jul; 128(3):395-404. PubMed ID: 27063952
[TBL] [Abstract][Full Text] [Related]
17. Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells.
Avci NG; Fan Y; Dragomir A; Akay YM; Gomez-Manzano C; Fueyo-Margareto J; Akay M
IEEE Trans Nanobioscience; 2015 Dec; 14(8):946-51. PubMed ID: 26661633
[TBL] [Abstract][Full Text] [Related]
18. The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture.
Haley EM; Kim Y
Cancer Lett; 2014 Apr; 346(1):1-5. PubMed ID: 24333730
[TBL] [Abstract][Full Text] [Related]
19. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
20. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids.
De Witt Hamer PC; Van Tilborg AA; Eijk PP; Sminia P; Troost D; Van Noorden CJ; Ylstra B; Leenstra S
Oncogene; 2008 Mar; 27(14):2091-6. PubMed ID: 17934519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
